What are the equivalent doses of doxepin and trazodone for insomnia and for antidepressant/anxiolytic therapy?

Equivalent Dosing Between Doxepin and Trazodone

For insomnia, doxepin 3-6 mg is the preferred agent over trazodone at any dose, as trazodone lacks evidence for efficacy in chronic insomnia and is specifically advised against by VA/DoD guidelines, while for antidepressant therapy, trazodone 401 mg is approximately equivalent to doxepin 140 mg based on systematic dose-equivalence research.

Context-Specific Dosing

For Insomnia Treatment

The 2019 VA/DoD guidelines explicitly advise against using trazodone for chronic insomnia disorder due to lack of efficacy—systematic reviews found no differences between trazodone (50-150 mg) and placebo for sleep efficiency or discontinuation rates, with only subjective sleep quality showing improvement 1. In contrast, low-dose doxepin (3-6 mg) demonstrated clear efficacy for sleep maintenance, total sleep time, and sleep quality in multiple RCTs, with no significant adverse event differences from placebo 1.

Clinical Algorithm for Insomnia:

• First-line: CBT-I (cognitive behavioral therapy for insomnia)
• If pharmacotherapy needed: Doxepin 3-6 mg at bedtime
• Avoid: Trazodone (insufficient evidence despite widespread off-label use)

The evidence is particularly strong here—while trazodone remains the most commonly prescribed off-label sleep aid 2, this practice contradicts guideline recommendations based on systematic evidence showing it performs no better than placebo for objective sleep parameters 1.

For Antidepressant/Anxiolytic Therapy

When used at antidepressant doses, the dose equivalence based on systematic analysis of 83 RCTs (14,131 participants) comparing antidepressants to fluoxetine 40 mg/day found 3:

• Doxepin 140.1 mg/day ≈ Fluoxetine 40 mg/day
• Trazodone 401.4 mg/day ≈ Fluoxetine 40 mg/day

Therefore, the approximate equivalent ratio is: Trazodone 401 mg ≈ Doxepin 140 mg (roughly 2.9:1 ratio).

For depression with insomnia, the FDA-approved dosing differs substantially from hypnotic dosing 4:

• Doxepin antidepressant range: 75-150 mg/day (up to 300 mg for severe illness)
• Trazodone antidepressant range: 150-300 mg/day (based on clinical literature 5)

A 1984 double-blind study found trazodone 50-200 mg once daily approximately equivalent to doxepin 25-100 mg once daily for antidepressant and anxiolytic effects 6, though this suggests a different ratio (approximately 2:1) than the larger systematic review.

Critical Dosing Distinctions

The most important clinical caveat: These are NOT interchangeable medications at equivalent doses due to vastly different mechanisms and indications:

• Low-dose doxepin (3-6 mg) works via H1-receptor antagonism for sleep—this is 20-50 times lower than antidepressant doses
• Trazodone lacks a validated low-dose hypnotic indication; doses below 100 mg show inconsistent effects 2

A recent 2025 retrospective study directly compared trazodone 100 mg versus doxepin 25 mg after trazodone 50 mg failure and found no significant difference in treatment failure rates (35.2% vs 41.2%, p=0.58) 7. However, this used doxepin at 8-fold higher than the FDA-approved hypnotic dose, making interpretation difficult.

Safety Considerations

Doxepin advantages:

• Lower anticholinergic burden at 3-6 mg doses
• No black box warning at hypnotic doses (though suicidality risk cannot be excluded) 1
• Minimal next-day residual effects at low doses 8

Trazodone disadvantages for insomnia:

• Dose-dependent side effects: dizziness, sedation, somnolence 5, 9
• Priapism risk (rare but serious)
• Higher adverse effect burden compared to placebo 10
• Tolerance develops to sedative effects after 3-4 days of antihistamine-mediated sedation 1

For elderly patients: Both require cautious dosing. Doxepin should start at low doses due to oversedation risk 4. The VA/DoD guidelines specifically note doxepin 3-6 mg showed efficacy in older adults 1.

Practical Switching Algorithm

When switching from trazodone to doxepin for insomnia:

1. Discontinue trazodone (no taper needed for short-term use)
2. Start doxepin 3 mg at bedtime
3. Increase to 6 mg if inadequate response after 3-7 days
4. Maximum hypnotic dose: 6 mg

When switching between antidepressant doses:

1. Use the 2.9:1 ratio (trazodone:doxepin) as starting point
2. Example: Trazodone 150 mg ≈ Doxepin 52 mg (round to 50 mg)
3. Cross-taper over 1-2 weeks given different receptor profiles
4. Monitor for anticholinergic effects with doxepin, orthostatic hypotension with trazodone

The evidence strongly favors doxepin over trazodone specifically for insomnia treatment, while for depression both have roles but are not simply interchangeable due to different mechanisms, side effect profiles, and dosing paradigms.